CN1857589A - Method of measuring icariin and epimedin c content in Xianlinggubao preparation - Google Patents
Method of measuring icariin and epimedin c content in Xianlinggubao preparation Download PDFInfo
- Publication number
- CN1857589A CN1857589A CN 200610200322 CN200610200322A CN1857589A CN 1857589 A CN1857589 A CN 1857589A CN 200610200322 CN200610200322 CN 200610200322 CN 200610200322 A CN200610200322 A CN 200610200322A CN 1857589 A CN1857589 A CN 1857589A
- Authority
- CN
- China
- Prior art keywords
- epimedin
- icariin
- content
- preparation
- reference substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention discloses the method of measuring icariin and epimedin C content in Xianlinggubao preparation, and the method is one high efficiency liquid chromatography method with icariin and epimedin C contrast and acetonitrile/water as flowing phase. Compared with available technology, the method adopts high efficiency separating column, replacement of the flowing phase component to separate icariin and epimedin C peaks completely, content limit redetermined based on experiment, increased epimedin C content limit with relatively greater peak area, and determined ratio range between icariin and epimedin C, so as to perfect the quality detection standard of Xianlinggubao preparation and ensure the medicine safe, effective and reliable.
Description
Technical field: the present invention relates to the content assaying method of icariin and epimedin in a kind of XIANLING GUBAO ZHIJI, belong to drug quality control technology field.
Background technology: the contained chemical constituent of Herba Epimedii is flavonoid, lignan's class, volatile oil, ceryl alcohol, hentriacontane, plant sterol, tannin and oils etc.Herba Epimedii has kidney-replenishing, bone and muscle strengthening, and the effect of wind-damp dispelling is mainly used in impotence and seminal emission, and the muscles and bones flaccidity is soft, rheumatic arthralgia, numbness contracture, diseases such as climacteric hypertension.XIANLING GUBAO ZHIJI is combined by Herba Epimedii, Radix Dipsaci, Radix Salviae Miltiorrhizae, the Rhizoma Anemarrhenae, Fructus Psoraleae and Radix Rehmanniae, has nourishing the liver and kidney, and reunion of bone is kept fit the function of strong bone, is mainly used in osteoporosis and osteoporosis, fracture, osteoarthritis, aseptic necrosis of bone etc.In XIANLING GUBAO ZHIJI, monarch drug in the Herba Epimedii side of being plays a part crucial reinforcing the kidney and supporting YANG, strengthening the tendons and bones, therefore can effectively control the quality of XIANLING GUBAO ZHIJI to the assay of epimedium herb in the preparation, thereby guarantee its clinical efficacy.
At present, the index composition of the epimedium herb that pharmacopeia requires only is an icariin, find through experimental study: owing to be subjected to condition restriction, icariin peak and epimedin peak overlapping caused content higher in the mensuration process when former content Determination of Icariin bioassay standard was set up.And learn after deliberation: the content of epimedin is higher than other flavones ingredients far away in the effective site in the Herba Epimedii (total flavones).So necessity of the quality standard that increases epimedium herb index composition is arranged, promptly increases the assay of epimedin.
Summary of the invention:
The objective of the invention is to: the content assaying method that icariin and epimedin in a kind of XIANLING GUBAO ZHIJI are provided, the present invention on the basis of existing technology, adopt the high efficiency separation post, the mobile phase component is changed, the icariin peak is thoroughly separated with the epimedin peak, and reformulated content limit through overtesting, increased the content limit of the epimedin that wherein peak area is bigger, thereby formulated proportion between the two, made the quality inspection standard of XIANLING GUBAO ZHIJI more perfect.
XIANLING GUBAO ZHIJI of the present invention is to be prepared from by Herba Epimedii, Radix Dipsaci, Radix Salviae Miltiorrhizae, the Rhizoma Anemarrhenae, Fructus Psoraleae and the Radix Rehmanniae relevant criterion [as WS-10269 (ZD-0269)-2002, WS-10289 (ZD-0289)-2002] according to China national Drug Administration.
The content assaying method of icariin and epimedin is to be contrast with icariin and epimedin reference substance in the XIANLING GUBAO ZHIJI of the present invention, and with acetonitrile: water is the high performance liquid chromatography of mobile phase.
Specifically, the content assaying method of icariin and epimedin is in the XIANLING GUBAO ZHIJI:
According to an appendix VID of Chinese Pharmacopoeia version in 2005 high effective liquid chromatography for measuring:
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; Acetonitrile: water=25: 75 is mobile phase; The detection wavelength is 270nm; Number of theoretical plate calculates by the epimedin peak should be lower than 5000; Number of theoretical plate calculates by the icariin peak should be lower than 5000;
It is an amount of that the preparation precision of reference substance solution takes by weighing in the phosphorus pentoxide vacuum drying apparatus dry 36 hours icariin and epimedin reference substance, add methanol and make the mixed solution that every 1ml contains icariin and epimedin 50 μ g, 25 μ g respectively, product solution in contrast, promptly;
This preparation or its content under the content uniformity item got in the preparation of need testing solution, and porphyrize is got 0.5g, the accurate title, decide, and puts in the tool plug conical flask, the accurate Diluted Alcohol 50ml that adds, claim to decide weight, supersound process is 30~60 minutes under power 250W, frequency 25kHz, puts cold, claim again to decide weight, supply the weight that subtracts mistake, shake up with Diluted Alcohol, get supernatant, filter, get subsequent filtrate, promptly;
Algoscopy is drawn reference substance solution and each 10 μ l of need testing solution respectively, injects chromatograph of liquid, measures, promptly;
Every of this capsule contains epimedin and icariin must not be less than 1.0mg, 0.5mg respectively, and epimedin and icariin peak area ratio must not be less than 2: 1.
In order to ensure content assaying method science of the present invention, reasonable, feasible, the applicant has carried out following experimental study:
1. the selection of assay index components
Herba Epimedii is the monarch drug in the XIANLING GUBAO ZHIJI side, Herba Epimedii mainly contains flavone compound, comprise epimedin, icariin, also contain composition and lignin compositions such as icariin-I, icariin-C, hyperin, precious icariin-I, rhamanopyranosyl icariside-II, arrow icariin B, precious icariin-II, Flos Caryophylli icariin C and Flos Caryophylli icariin F.Has kidney-replenishing, bone and muscle strengthening, the effect of wind-damp dispelling.Modern pharmacology studies show that Herba Epimedii has the raising sexual function, enhancing immunity, and the protection heart improves myocardial ischemia, increases coronary flow, anti-arrhythmia, blood pressure lowering, antiplatelet aggregation, antiinflammatory, the anti-ageing effect of waiting for a long time.Through correlational study as can be known: the content of epimedin is higher than other flavones ingredients far away in the effective site in the Herba Epimedii (total flavones), therefore, is necessary to increase the assay of epimedin, further to improve the quality standard of Herba Epimedii index composition.
In order to finish the present invention, the applicant investigates the epimedium herb extraction process, determine optimum extraction process, and prepare a large amount of epimedins, the total flavones process of enriching is investigated, use macroporous resin and carry out epimedin and separate, purification, and formulated that specificity is strong, highly sensitive, the high performance liquid chromatography of stability and favorable reproducibility, reliable results.
2. instrument and reagent
Instrument: high performance liquid chromatograph Agilent1100, DAD detector, Agilent work station.
Chromatographic column: Agilent ODS 5 μ m 4.0 * 250mm
Reference substance: icariin, epimedin.
Reagent: acetonitrile (chromatographically pure, Fisher), WAHAHA pure water (Hangzhou Wahaha Group Co.,Ltd), ethanol (analytical pure, Beijing Chemical Plant).
3. method and result
3.1 chromatographiccondition
Mobile phase: acetonitrile-water (25: 75); Flow velocity: 1ml/min; Detect wavelength: 270nm; Number of theoretical plate calculates by epimedin and is not less than 5000.
3.2 selection of experiment conditions
3.2.1 measure the selection of wavelength:
With dissolve with methanol epimedin reference substance, make the solution that every 1ml contains 0.05mg, the U-2000 type visible-measure absorption spectrum on the uv-spectrophotometric instrument, the result has absorption maximum at 270nm place, so selection 270nm is as the detection wavelength.
3.2.2 the selection of mobile phase:
Acetonitrile-water (30: 70) on probation, the peak type is bad, and separating effect is very undesirable.
Change acetonitrile-water (24: 76) into, reach preferably and separate.
3.2.3 blank assay
The preparation of blank solution is the ratio in the prescription taste of Chinese medicine, autogamy does not contain group's medicine of Herba Epimedii, make blank preparation by its technology, press need testing solution preparation method preparation again and measure, blank solution is not being seen chromatographic peak with epimedin, retention time place that the icariin reference substance is identical as a result.
3.2.4 extracting solvent selects:
Take by weighing XIANLING GUBAO ZHIJI 0.5g (lot number 051209), the accurate title, decide, and puts in the tool plug conical flask, adds methanol, Diluted Alcohol, each 50ml of ethanol respectively, and supersound process 1 hour is measured its icariin and epimedin content.The results are shown in Table 1:
The different influences of extracting solvent of table 1 to epimedin, icariin content
Extract solvent | Methanol | Diluted Alcohol | Ethanol |
Epimedin content (mg/g) icariin content (mg/g) | 3.2642 1.5642 | 4.0537 1.7577 | 3.7135 1.4128 |
The result shows that the effect of Diluted Alcohol do extraction solvent is best.Therefore, select for use Diluted Alcohol to extract as extracting solvent.
3.2.5 extraction time is determined:
Take by weighing XIANLING GUBAO ZHIJI 0.5g (lot number 051209), the accurate title, decide, and puts in the tool plug conical flask, add Diluted Alcohol 50ml respectively, supersound process (power 250W, frequency 25KHz) each 0.5,1.0,1.5 hour, measure the content of its icariin and epimedin, the results are shown in Table 2:
Table 2 different extraction times are to the influence of epimedin, icariin content
Extraction time (min) | 0.5 | 1.0 | 1.5 |
Epimedin content (mg/g) icariin content (mg/g) | 3.1243 1.6507 | 4.1584 1.7385 | 4.2069 1.7315 |
According to above result, select supersound extraction 1 hour comparatively suitable.
3.3 linear relationship is investigated
Accurate epimedin reference substance solution (0.0404mg/ml) 2,4,8,12, the 16 μ l that draw, inject chromatograph of liquid, the record peak area, (μ g) is abscissa with reference substance epimedin sample size, is vertical coordinate with the peak area, the drawing standard curve, its regression equation is A=1509.3524X+13.7157 (r=0.9992), brings the disconnected minimum point value of linearity into following formula and calculates, and relative deviation is less than 1% as a result, think that working curve was similar to initial point, therefore adopt the appearance one point method to calculate.The result shows that the epimedin sample size is the good linear relation in 0.0808~0.6464 μ g scope.
In like manner, accurate icariin reference substance solution (0.1004mg/ml) 1,3,5,8, the 10 μ l that draw, inject chromatograph of liquid, the record peak area, (μ g) is abscissa with reference substance icariin sample size, with the peak area is vertical coordinate, the drawing standard curve, its regression equation is Y=2109.8x+4.6272 (r=0.9998), fitting to former point equation is: Y=2115.063X, and bring the short minimum point value of linearity into above-mentioned two formulas and calculate, relative deviation is 0.96% as a result, think that working curve was similar to initial point, therefore adopt one point external standard method to calculate.The result shows that the icariin sample size is the good linear relation in 0.10~1.2 μ g scope.The results are shown in Table 3, table 4.
Table 3 epimedin linear relationship is investigated
Sampling volume (μ l) | 2 | 4 | 8 | 12 | 16 |
Sample size (μ g) | 0.0808 | 0.1616 | 0.3232 | 0.4848 | 0.6464 |
Peak area (Mau*s) | 125.24849 | 257.19345 | 511.98727 | 762.33679 | 972.88281 |
Table 4 icariin linear relationship is investigated
The amount of icariin (μ g) | 0.1004 | 0.3012 | 0.5020 | 0.8032 | 1.004 | 1.2048 |
Peak area (Mau*s) | 200.660 | 639.502 | 1076.194 | 1727.701 | 2112.015 | 2532.912 |
3.4 stability test
Get same test sample (lot number 051214) 0.5g, the need testing solution preparation method is prepared in the reference standard, respectively at preparation back 0,2,4,6,8,10 hours, measure epimedin and icariin peak area according to last method, the record peak area value, the result shows that need testing solution is good at 10 hours internal stabilities, sees Table 5,6.
Table 5 epimedin stability experiment
Time | Peak area (Mau*s) | Average | RSD(%) |
0 | 725.74371 | 712.788 | 1.131 |
2 | 719.83386 | ||
4 | 705.53790 | ||
6 | 707.99670 | ||
8 | 708.32776 | ||
10 | 709.28516 |
Table 6 icariin stability experiment
Time | Peak area (Mau*s) | Average | RSD(%) |
0 | 1012.313 | 1025.003 | 1.29% |
2 | 1022.716 | ||
4 | 1020.080 | ||
6 | 1047.485 | ||
8 | 1022.419 |
3.5 precision test
Accurate same epimedin (C=0.0404mg/ml), each 10 μ l of icariin (C=0.1004mg/ml) reference substance solution of drawing repeat sample introduction 6 times, measure peak area and write down collection of illustrative plates, the results are shown in Table 7,8.The result shows that precision meets the requirements.
The test of table 7 epimedin precision
Peak area (Mau*s) | Average | RSD(%) | |
1 | 639.66168 | 641.371 | 0.188 |
2 | 641.82422 | ||
3 | 641.55096 | ||
4 | 640.18201 | ||
5 | 642.76141 | ||
6 | 642.24707 |
The test of table 8 icariin precision
Peak area (Mau*s) | Average | RSD(%) | |
1 | 2161.172 | ||
2 | 2118.171 | ||
3 | 2166.837 | 2133.01 | 1.36 |
4 | 2115.738 | ||
5 | 2103.102 |
3.6 replica test
Same lot number (051214) sample is taken by weighing 5 parts, prepare test liquid, measure its epimedin and icariin content in accordance with the law, the results are shown in Table 9,10 by the method under the assay item of the present invention.Experimental result shows that this method repeatability is good.
Epimedin measurement result in table 9 replica test
Sample size (g) | Chao Huoding C content (mg/g) | Average content (mg/g) | RSD(%) | |
1 | 0.5042 | 4.4074 | 4.4561 | 1.78 |
2 | 0.5025 | 4.4805 | ||
3 | 0.5023 | 4.5336 | ||
4 | 0.5128 | 4.3439 | ||
5 | 0.5007 | 4.5151 |
Icariin measurement result in table 10 replica test
Sample size (g) | Icariin content (mg/g) | Average content (mg/g) | RSD(%) | |
1 | 0.5042 | 1.9856 | 1.9909 | 0.79 |
2 | 0.5025 | 1.9892 | ||
3 | 0.5023 | 1.9692 | ||
4 | 0.5128 | 2.0115 | ||
5 | 0.5007 | 1.9988 |
3.7 recovery test
Adopt the application of sample absorption method.Precision takes by weighing the same lot number (lot number 051214 of known content, known epimedin and icariin content are respectively 4.4561mg/g, 1.9909mg/g) the about 0.25g of sample each 5 parts, the accurate title, decide, accurate respectively adding epimedin and icariin mix each 50ml of reference substance solution and (get epimedin, icariin reference substance, add Diluted Alcohol and make the solution that concentration is respectively 0.024mg/ml, 7.52 μ g/ml), preparation method preparation and above-mentioned chromatographic condition by test liquid under the assay item of the present invention are measured calculate recovery rate.The results are shown in Table 11,12.
Epimedin recovery test and result in the celestial Ling Neibao capsule of table 11
Sequence number | Sample sample weighting amount (g) | Sample epimedin amount (mg) | Add epimedin amount (mg) | The epimedin amount of recording (mg) | The response rate (%) | Average recovery rate (%) | RSD (%) |
1 | 0.2505 | 1.1163 | 1.20 | 2.3135 | 99.77 | 100.11 | 1.99 |
2 | 0.2486 | 1.1078 | 1.20 | 2.3340 | 102.18 | ||
3 | 0.2517 | 1.1216 | 1.20 | 2.3442 | 101.88 | ||
4 | 0.2609 | 1.1630 | 1.20 | 2.3308 | 97.32 | ||
5 | 0.2526 | 1.1256 | 1.20 | 2.3182 | 99.38 |
Icariin recovery test and result in the celestial Ling Neibao capsule of table 12
Sequence number | Sample sample weighting amount (g) | The icariin amount of recording (mg) | Sample icariin amount (mg) | Add icariin amount (mg) | The response rate (%) | Average recovery rate (%) | RSD (%) |
1 | 0.2505 | 0.8755 | 0.4987 | 0.376 | 100.21 | 97.47 | 2.19 |
2 | 0.2486 | 0.8591 | 0.4949 | 96.86 | |||
3 | 0.2517 | 0.8608 | 0.5011 | 95.66 | |||
4 | 0.2609 | 0.8923 | 0.5194 | 99.18 | |||
5 | 0.2526 | 0.8617 | 0.5029 | 95.42 |
Above result shows that epimedin and icariin average recovery rate are respectively 100.11%, 97.47%, and RSD is respectively 1.99%, 2.19%.Illustrate that this method is feasible.
According to above result of the test, the condition of content assaying method of the present invention is defined as: with octadecylsilane chemically bonded silica is filler; Acetonitrile-water (25: 75) is a mobile phase; Flow velocity: 1.0ml/min; The detection wavelength is 270nm.Number of theoretical plate calculates by the epimedin peak should be not less than 5000.
Need testing solution preparation method of the present invention is defined as: get this preparation or its content under the content uniformity item, porphyrize is got 0.5g, the accurate title, decide, and puts in the tool plug conical flask, the accurate Diluted Alcohol 50ml that adds, claim to decide weight, supersound process (power 250W, frequency 25kHz) 1 hour, put cold, claim again to decide weight, supply the weight that subtracts mistake, shake up with ethanol, filter, promptly.
3.8 this algoscopy of assay computational methods adopts one point external standard method to calculate content, precision takes by weighing test sample 0.5g, prepares test liquid by quality standard, and sample introduction is measured, and computing formula is as follows.
(1) need testing solution concentration is calculated:
In the formula: C
S: be need testing solution concentration (mg/ml).
C
R: be reference substance solution concentration (mg/ml).
A
s: be need testing solution peak area value (mAu*s)
A
R: be reference substance solution peak area value (mAu*s)
(2) formulation content computing formula:
In the formula: C
s: need testing solution concentration (mg/ml)
V
S: be the volume (ml) of need testing solution.
W
1: be the weighing (g) of sample.
W
2: be average particle heavy (g).
Merge (1) (2) formula, its computing formula is (3):
3.9 sample determination and content limit are formulated us to ten batches of our company " XIANLING GUBAO JIAONANG ", by its epimedin of above-mentioned high effective liquid chromatography for measuring and icariin content, the results are shown in Table 13.
Table 13 epimedin measurement result table
Lot number | Epimedin average peak area (Mau*s) (n=2) | Chao Huoding C average content (mg/ grain) (n=2) | Icariin average peak area (Mau*s) (n=2) | Icariin average content (mg/ grain) (n=2) | ||||
040905 041001 041010 041013 050718 051204 051207 051208 051210 051212 | 469.256 | 473.598 | 0.958 | 0.979 | 244.278 | 248.595 | 0.486 | 0.477 |
546.859 | 551.105 | 1.561 | 1.529 | 319.742 | 308.815 | 0.569 | 0.575 | |
915.716 | 922.924 | 2.407 | 2.384 | 419.598 | 403.426 | 0.671 | 0.658 | |
745.802 | 740.298 | 1.655 | 1.591 | 268.069 | 257.332 | 0.516 | 0.528 | |
I380.982 | 1389.703 | 2.964 | 2.896 | 347.301 | 354.459 | 0.612 | 0.606 | |
941.804 | 940.704 | 2.451 | 2.440 | 334.781 | 337.916 | 0.715 | 0.728 | |
983.635 | 992.806 | 2.615 | 2.528 | 297.723 | 290.498 | 0.551 | 0.548 | |
834.491 | 849.264 | 1.726 | 1.735 | 479.682 | 469.251 | 0.865 | 0.837 | |
1024.562 | 1025.796 | 2.685 | 2.706 | 311.879 | 309.765 | 0.914 | 0.925 | |
974.672 | 949.236 | 2.562 | 2.511 | 318.255 | 313.206 | 0.584 | 0.576 |
According to above epimedin and ten batches of peak areas of icariin and assay result, every contains epimedin and icariin must not be less than 1.0mg, 0.5mg respectively in tentative " XIANLING GUBAO JIAONANG ", and epimedin and icariin peak area ratio must not be less than 2: 1.
Compared with prior art, content assaying method of the present invention adopts the high efficiency separation post, the mobile phase component is changed, the icariin peak is thoroughly separated with the epimedin peak, and reformulated content limit through overtesting, increase the content limit of the epimedin that wherein peak area is bigger, thereby formulated proportion between the two, make the quality inspection standard of XIANLING GUBAO ZHIJI more perfect, thereby guaranteed safety, effectiveness, the reliability of medicine.
The specific embodiment:
Embodiments of the invention 1: the content assaying method of icariin and epimedin is in the XIANLING GUBAO ZHIJI:
According to an appendix VID of Chinese Pharmacopoeia version in 2005 high effective liquid chromatography for measuring:
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; Acetonitrile: water=25: 75 is mobile phase; The detection wavelength is 270nm; Number of theoretical plate calculates by the epimedin peak should be lower than 5000;
It is an amount of that the preparation precision of reference substance solution takes by weighing in the phosphorus pentoxide vacuum drying apparatus dry 36 hours icariin and epimedin reference substance, add methanol and make the mixed solution that every 1ml contains icariin and epimedin 50 μ g, 25 μ g respectively, product solution in contrast, promptly;
This preparation or its content under the content uniformity item got in the preparation of need testing solution, and porphyrize is got 0.5g, the accurate title, decide, and puts in the tool plug conical flask, the accurate Diluted Alcohol 50ml that adds, claim to decide weight, supersound process is 60 minutes under power 250W, frequency 25kHz, puts cold, claim again to decide weight, supply the weight that subtracts mistake, shake up with ethanol, get supernatant, filter, get subsequent filtrate, promptly;
Algoscopy is drawn reference substance solution and each 10 μ l of need testing solution respectively, injects chromatograph of liquid, measures, promptly;
Every of this capsule contains epimedin and icariin must not be less than 1.0mg, 0.5mg respectively, and epimedin and icariin peak area ratio must not be less than 2: 1.
Claims (2)
1. the content assaying method of icariin and epimedin in the XIANLING GUBAO ZHIJI is characterized in that: it is to be contrast with icariin and epimedin reference substance, and with acetonitrile: water is the high performance liquid chromatography of mobile phase.
2. according to the content assaying method of icariin and epimedin in the described XIANLING GUBAO ZHIJI of claim 1, it is characterized in that: concrete assay method is:
According to an appendix VID of Chinese Pharmacopoeia version in 2005 high effective liquid chromatography for measuring:
Chromatographic condition and system suitability test are filler with octadecylsilane chemically bonded silica; Acetonitrile: water=25: 75 is mobile phase; The detection wavelength is 270nm; Number of theoretical plate calculates by the epimedin peak should be lower than 5000; Number of theoretical plate calculates by the icariin peak should be lower than 5000;
It is an amount of that the preparation precision of reference substance solution takes by weighing in the phosphorus pentoxide vacuum drying apparatus dry 36 hours icariin and epimedin reference substance, add methanol and make the mixed solution that every 1ml contains icariin and epimedin 50 μ g, 25 μ g respectively, product solution in contrast, promptly;
This preparation or its content under the content uniformity item got in the preparation of need testing solution, and porphyrize is got 0.5g, the accurate title, decide, and puts in the tool plug conical flask, the accurate Diluted Alcohol 50ml that adds, claim to decide weight, supersound process is 30~60 minutes under power 250W, frequency 25kHz, puts cold, claim again to decide weight, supply the weight that subtracts mistake, shake up with Diluted Alcohol, get supernatant, filter, get subsequent filtrate, promptly;
Algoscopy is drawn reference substance solution and each 10 μ l of need testing solution respectively, injects chromatograph of liquid, measures, promptly;
Every of this capsule contains epimedin and icariin must not be less than 1.0mg, 0.5mg respectively, and epimedin and icariin peak area ratio must not be less than 2: 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200610200322 CN1857589A (en) | 2006-04-06 | 2006-04-06 | Method of measuring icariin and epimedin c content in Xianlinggubao preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200610200322 CN1857589A (en) | 2006-04-06 | 2006-04-06 | Method of measuring icariin and epimedin c content in Xianlinggubao preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1857589A true CN1857589A (en) | 2006-11-08 |
Family
ID=37296577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200610200322 Pending CN1857589A (en) | 2006-04-06 | 2006-04-06 | Method of measuring icariin and epimedin c content in Xianlinggubao preparation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1857589A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102391335A (en) * | 2011-07-29 | 2012-03-28 | 贵州同济堂制药有限公司 | Isopentene flavonol glycoside derivative and preparation method and application thereof |
CN102768248A (en) * | 2012-05-29 | 2012-11-07 | 贵州富华药业有限责任公司 | Method for determining Epimedin C and icariin content of Gusongbao preparation |
CN103698454A (en) * | 2013-12-17 | 2014-04-02 | 广西中烟工业有限责任公司 | Detection method for measuring effective constituents of epimedium in cigarette tobacco shreds and main stream smoke of cigarettes |
CN104711301A (en) * | 2015-03-24 | 2015-06-17 | 北京盛诺基医药科技有限公司 | Icaritin preparation method |
CN105535154A (en) * | 2015-12-24 | 2016-05-04 | 河南大学 | Filamental flowering crab extract, active compound, preparing method and application |
CN109187810A (en) * | 2018-10-29 | 2019-01-11 | 广州白云山陈李济药厂有限公司 | A kind of detection method for treating rheumatoid arthritis Chinese medicine composition |
CN110672747A (en) * | 2019-10-23 | 2020-01-10 | 劲牌生物医药有限公司 | Method for detecting epimedium component, method for identifying variety of epimedium and application |
CN110794059A (en) * | 2019-11-13 | 2020-02-14 | 亚宝药业四川制药有限公司 | Detection method of yang strengthening tablet |
CN112816603A (en) * | 2021-01-05 | 2021-05-18 | 天津中医药大学 | Bone-strengthening joint pill fingerprint spectrum and method for detecting 18 components in bone-strengthening joint pill fingerprint spectrum |
-
2006
- 2006-04-06 CN CN 200610200322 patent/CN1857589A/en active Pending
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102391335A (en) * | 2011-07-29 | 2012-03-28 | 贵州同济堂制药有限公司 | Isopentene flavonol glycoside derivative and preparation method and application thereof |
CN102391335B (en) * | 2011-07-29 | 2014-02-19 | 贵州同济堂制药有限公司 | Isopentene flavonol glycoside derivative and preparation method and application thereof |
CN102768248A (en) * | 2012-05-29 | 2012-11-07 | 贵州富华药业有限责任公司 | Method for determining Epimedin C and icariin content of Gusongbao preparation |
CN103698454A (en) * | 2013-12-17 | 2014-04-02 | 广西中烟工业有限责任公司 | Detection method for measuring effective constituents of epimedium in cigarette tobacco shreds and main stream smoke of cigarettes |
CN104711301A (en) * | 2015-03-24 | 2015-06-17 | 北京盛诺基医药科技有限公司 | Icaritin preparation method |
CN105535154A (en) * | 2015-12-24 | 2016-05-04 | 河南大学 | Filamental flowering crab extract, active compound, preparing method and application |
CN105535154B (en) * | 2015-12-24 | 2019-08-06 | 河南大学 | Hall crabapple flower extract and reactive compound, preparation method and application |
CN109187810A (en) * | 2018-10-29 | 2019-01-11 | 广州白云山陈李济药厂有限公司 | A kind of detection method for treating rheumatoid arthritis Chinese medicine composition |
CN109187810B (en) * | 2018-10-29 | 2021-06-08 | 广州白云山陈李济药厂有限公司 | Detection method of traditional Chinese medicine composition for treating rheumatoid arthritis |
CN110672747A (en) * | 2019-10-23 | 2020-01-10 | 劲牌生物医药有限公司 | Method for detecting epimedium component, method for identifying variety of epimedium and application |
CN110794059A (en) * | 2019-11-13 | 2020-02-14 | 亚宝药业四川制药有限公司 | Detection method of yang strengthening tablet |
CN112816603A (en) * | 2021-01-05 | 2021-05-18 | 天津中医药大学 | Bone-strengthening joint pill fingerprint spectrum and method for detecting 18 components in bone-strengthening joint pill fingerprint spectrum |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1857589A (en) | Method of measuring icariin and epimedin c content in Xianlinggubao preparation | |
CN100335897C (en) | Quality detection method for compound prepn of red sage and notoginseng | |
CN1895408A (en) | Radix saposhnikoviae Tong Sheng capsules, preparation and quality control thereof | |
CN1141575C (en) | Red sage medicine fingerprint establishing method and standard fingerprint atlas | |
CN101049389A (en) | Method for controlling quality of granule preparation for treating chilly sensation type gastritis | |
CN106370738B (en) | Fingerprint quality determination method for periplaneta americana medicinal material | |
CN101028388A (en) | Quality inspection of Chinese-medicinal preparation for treating shortsighness and asthenopia | |
CN104897787A (en) | Method for simultaneous determination of six active components in Niuhuang Ninggong tablet | |
CN102426205B (en) | Detection method of thrombus sumalin capsules | |
CN101028460A (en) | Method for inspecting throat-clearing Chinese medicinal pills | |
CN101029889A (en) | Method for inspecting Chinese medicinal preparation quality in treatment of old man eyes dieases | |
CN104569195B (en) | A kind of method of flavonoids effective constituent content in toothpaste detected containing baikal skullcap root | |
CN1932506A (en) | Method for establishing evodia rutaecarpa liposoluble fingerprint and standard fingerprint thereof | |
CN101028487A (en) | Chinese-medicinal preparation for treating eyeground bleeding and method for inspecting vision-improving prescription quality | |
CN101040951A (en) | Method of controlling the quality of Ynxingchao dropping pills compound | |
CN1844912A (en) | Earthworm fingerprint spectrum establishment method and medicinal earthworm identification method | |
CN1932507A (en) | Method for establishing evodia rutaecarpa water-soluble fingerprint and standard fingerprint thereof | |
CN1907340A (en) | Quality checking and controlling method for renal stone removal preparation | |
CN1844911A (en) | Leech fingerprint spectrum establishment method and medicinal leech identification method | |
CN1679811A (en) | Danshen root extract, production, medicine preparation and inspection thereof | |
CN1314789C (en) | Method for preparing pure oleum fructus brucease | |
CN111929378B (en) | Method for measuring content of 6 index components of gastrodia elata in Qingda granules | |
CN107582639A (en) | A kind of vinegar corydalis tuber granule and preparation method thereof | |
CN101029890A (en) | Method for inspecting Chinese-medicinal preparation Kaiyinwan | |
CN1840032A (en) | Granule for treating infant's rhinitis, its preparation method and quality control method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Open date: 20061108 |